share_log

Stifel Maintains Buy on HilleVax, Lowers Price Target to $30

Stifel Maintains Buy on HilleVax, Lowers Price Target to $30

Stifel维持对HilleVax的买入,将目标股价下调至30美元
Benzinga ·  2023/11/10 15:26

Stifel analyst Stephen Willey maintains HilleVax (NASDAQ:HLVX) with a Buy and lowers the price target from $35 to $30.

Stifel分析师斯蒂芬·威利维持HilleVax(纳斯达克股票代码:HLVX)的买入,并将目标股价从35美元下调至30美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发